Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584376 · ClinicalTrials.gov registry record · Phase 4
Pregabalin (Lyrica) for the Treatment of Essential Tremor
A Phase 4 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 29
- Enrollment target
NCT00584376 is a Phase 4 study that has completed, run by University of South Florida. The registered enrollment target is 29 participants.
The verdict
NCT00584376, a Phase 4 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29 participants
- Enrollment target
Study Summary
This will be a multi-site, prospective, double-blind, randomized, placebo-controlled, crossover trial conducted over 6 months to assess the effectiveness and safety of PGB to treat symptoms of ET.
Interventions
- DRUG Placebo
- DRUG Pregabalin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00584376
The ClinicalTrials.gov registry entry for NCT00584376 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00584376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00584376 about?
NCT00584376 is a clinical study titled "Pregabalin (Lyrica) for the Treatment of Essential Tremor". This will be a multi-site, prospective, double-blind, randomized, placebo-controlled, crossover trial conducted over 6 months to assess the effectiveness and safety of PGB to treat symptoms of ET.
What is the current status of trial NCT00584376?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29 participants. The study started on 2007-12. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00584376?
The interventions under investigation include: Placebo (DRUG), Pregabalin (DRUG).
Who is sponsoring clinical trial NCT00584376?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.